A GWAS study of the Dallas Heart study population has revealed that a polymorphism of PNPLA3 (rs738409; I148M) is strongly associated with increased hepatic fat levels and susceptibility to nonalcoholic fatty liver disease (Romeo et al. 2008). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.